# FDA Inspection 1237787 - KU Leuven Research & Development - May 03, 2024

Source: https://www.keypedia.com/records/fda_inspections/ku-leuven-research-development/4b1e57a3-eb7f-44ee-b718-9246284bfe9f
Source feed: FDA_Inspections

> FDA Inspection 1237787 for KU Leuven Research & Development on May 03, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1237787
- Company Name: KU Leuven Research & Development
- Inspection Date: 2024-05-03
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 976513 - 2016-04-14](https://www.keypedia.com/records/fda_inspections/ku-leuven-research-development/a06bdc97-4414-4940-9d01-61faf6a225f8)
- [FDA Inspection 694809 - 2010-09-16](https://www.keypedia.com/records/fda_inspections/ku-leuven-research-development/7c3eedac-d36a-449d-ab90-9593bddf8b9d)

Company: https://www.keypedia.com/companies/ku-leuven-research-development/7f59b9ed-f3a8-45fc-b588-c322282f8b0b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c